YARW Yarrow Bioscience, Inc.
Yarrow Bioscience, Inc. (YARW) is expected to report earnings on February 11, 2027, before the market open.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Yarrow Bioscience, Inc.
VYNE Therapeutics Inc. focuses on developing and commercializing therapeutics for dermatology. The company's product pipeline consist FMX103 and FCD105 which are in clinical stage. VYNE Therapeutics Inc., formerly known as Menlo Therapeutics Inc., is based in Bridgewater, New Jersey.
Charts powered in part by Lightweight Charts™ by TradingView.